<DOC>
	<DOCNO>NCT02639520</DOCNO>
	<brief_summary>To demonstrate non-inferiority non-antibiotic therapy CLR versus antibiotic treatment fosfomycin trometamol woman suffer acute low uUTIs measure proportion patient receive additional antibiotic treatment acute low uUTIs trial .</brief_summary>
	<brief_title>Efficacy CLR Compared Fosfomycin Trometamol Acute Lower uUTIs</brief_title>
	<detailed_description>The trial design comparison two different mode action order look alternative antibiotic treatment uncomplicated UTIs . Treatment CLR nonantibiotic therapy compare antibiotic treatment . Thus , trial aim reduce antibiotic use moreover reduce pressure develop bacterial resistance antibiotic due widespread use , additional advantage CLR therapy . The trial result expect demonstrate antibiotic prescription woman treatment low uUTIs reduce alternative safe non-antibiotic treatment .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Urinary Tract Infections</mesh_term>
	<mesh_term>Fosfomycin</mesh_term>
	<criteria>1 . Signed informed consent ( IC ) data protection declaration 2 . Female outpatient age 18 70 year 3 . Sumscore main uUTI symptom ( dysuria , pollakisuria , urgency ) report Acute Cystitis Symptom Score ( ACSS ) '' Typical '' domain Visit 1 ≥6 4 . Symptoms acute episode lower uUTI develop within 6 day prior Visit 1 5 . Leukocyturia Visit 1 , confirm positive dipstick 6 . Patients willing refrain consume prohibit concomitant medication product 7 . Nonlactating female patient surgically sterile ( documented sterilization , bilateral oophorectomy least 3 month start trial and/or hysterectomy ) , postmenopausal ( cessation menses least 12 month ) , woman childbearing potential negative pregnancy test Visit 1 willing use highly effective ( failure rate le 1 % per year , i.e. , Pearl Index &lt; 1 ) contraception method , e.g. , contraceptive patch , oral , injected implant hormonal method contraception , trial include followup period . 1 . Any sign complicate urinary tract infection ( UTIs ) , pyelonephritis ( i.e. , fever T ≥38.0°C [ grade 2 ] , flank and/or back pain , chill shiver ) , and/or vulvovaginitis vaginal and/or urethral discharge ( without urination ) Visit 1 . 2 . Any condition may lead complicated infection ( i.e. , renal disease , urinary tract abnormality past urinary surgery , urine catheterization , uncontrolled diabetes mellitus , spinal cord injury , etc. ) . 3 . Chronic infection urinary tract know medical history . 4 . Persisting sign symptom severe , progressive , uncontrolled systemic disease ( i.e. , renal , hepatic , biliary , hematological , gastrointestinal , endocrine , pulmonary , cardiac , neurological , cerebral disease ) . 5 . Uncontrolled hypertension ( diastolic blood pressure &gt; 95 mmHg Visit 1 ) . 6 . Known severe cardiac insufficiency , coronary heart disease , valvular heart disease , cardiac arrhythmia , QT interval prolongation severe cardiac disease Visit 1 . 7 . Any antibiotic therapy within 30 day prior Visit 1 . 8 . Other acute infection ( except uUTIs ) require antibiotic treatment Visit 1 . 9 . Patients receive treatment suspect confirmed UTI ( antibiotic phytopharmaceutical ) within 30 day prior Visit 1 . 10 . Patients take antiinflammatory drug ( e.g. , ibuprofen ) spasmolytic reason within 24 hour prior Visit 1 , and/or willing stop intake medication permit use trial . 11 . Known severe impaired renal function ( creatinine clearance &lt; 20 mL/min ) . 12 . Active peptic ulcer .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Uncomplicated urinary tract infection</keyword>
</DOC>